Purchases and Sales Made in Q4 2024 in Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX) during Q4 2024. The information is specifically focused on institutions that hold shares of Amylyx Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
6.37KNew |
$18.7K - $44.8K
|
6.37K
$22.7K
|
|
|
Jan 22, 2025
Q4 2024
|
Ronald Blue Trust, Inc.
Brentwood, TN |
BUY
|
- |
4.88K+ 232.08% |
$14.4K - $34.3K
|
6.99K
$24.9K
|
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
1.44K+ 11.01% |
$4.24K - $10.1K
|
14.5K
$51.7K
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-250- 33.56% |
$735 - $1.76K
|
495
$1.76K
|
|
|
Jan 22, 2025
Q4 2024
|
Parsons Capital Management Inc
|
SELL
|
- |
-300- 1.37% |
$882 - $2.11K
|
21.6K
$77.1K
|
|
|
Jan 14, 2025
Q4 2024
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-23.9K- 20.88% |
$70.3K - $168K
|
90.6K
$323K
|
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-41.4K- 72.19% |
$122K - $291K
|
16K
$56.8K
|
|
|
Jan 24, 2025
Q4 2024
|
Abrdn PLC
|
SELL
|
- |
-249K- 12.65% |
$733K - $1.75M
|
1.72M
$6.13M
|